ARCTIC BIOSCIENCE NK -10

Research ARCTIC BIOSCIENCE NK -10 (9TD) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• Ticker9TD
• ExchangeF
• CurrencyEUR
• Financial periodFY2024
• RevenueEUR 43.48M
• Revenue growth28.8%
• Net income-EUR 47.93M
• Free cash flow-EUR 96.17M
• Gross margin27.3%